Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
Source: The Hindu Business (English)
Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
Read full article on The Hindu Business (English)
Related News
Moves by the North of England to unlock India trade
Royal Stag, Blenders Pride, McDowell’s अडचणीत! कंपन्यांच्या कार्यालयांवर सरकारी छापेमारी; किंमती वाढणार?
Flipkart आता फूड डिलिव्हरी करणार, काय आहे ‘Eat-in by Minutes’ प्लान?
சொந்த வீடு வாங்க ஆசை இருந்தா இப்பவே வாங்கிடுங்க.. 2027ல் ஷாக் மேல ஷாக் காத்திருக்கு..!!
Amazon targets Nvidia’s software edge with new AI tool
SBI: స్టేట్ బ్యాంక్ ఆఫ్ ఇండియా ఖాతాదారుల వివరాలు లీక్ అయ్యాయా..!
